In addition, interestingly, we found a higher population of CD24−/low/CD44+ cells among RT-R-TNBC cells than among TNBC cells, and RT-R-TNBC cells showed more aggressive tumorigenic properties related to tumor cell growth, migration and invasion than the parental breast cancer cells [15]. This evidence concerns the gene CD44 and breast cancer.